Vol. 133 No. 1515
Vol. 133 No. 1515
Issue Number: 1515
VIEWPOINT
A balanced opinion? Considering the role of the external clinical advisor in ACC processes
Andrew Dickson, Joanna Manning
CLINICAL CORRESPONDENCE
Acute onset internuclear ophthalmoplegia responsive to treatment with intravenous alteplase
Karim M Mahawish, Adarsh Aravind
ARTICLE
Attitudes towards cannabis and cannabis law change in a New Zealand birth cohort
Joseph M Boden, Lana Cleland, Bhubaneswor Dhakal, L John Horwood
LETTER
Beyond COVID-19: five actions which would improve the health of all New Zealanders
Emma Espiner, Selah Hart, Garth Poole, Tamara Glyn Mullaney, Su Mei Hoh
ARTICLE
Cannabis-based medicinal products in arthritis, a painful conundrum
Marthe Van den Berg, Mary John, Melissa Black, Alex Semprini, Karen Oldfield, Michelle Glass, Irene Braithwaite
VIEWPOINT
Challenges of virtual talking therapies for substance misuse in New Zealand during the COVID-19 pandemic: an opinion piece
Susanna Galea-Singer, David Newcombe, Virginia Farnsworth-Grodd, Janie Sheridan, Peter Adams, Natalie Walker
ARTICLE
Exploring medicinal use of cannabis in a time of policy change in New Zealand
Marta Rychert, Chris Wilkins, Karl Parker, Thomas Graydon-Guy
ARTICLE
Increasing burden of advanced hepatocellular carcinoma in New Zealand—the need for better surveillance
Cameron Schauer, Thomas Mules, Marius van Rijnsoever, Ed Gane
VIEWPOINT
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection
Rohan Ameratunga, Klaus Lehnert, Euphemia Leung, Davide Comoletti, Russell Snell, See-Tarn Woon, William Abbott, Emily Mears, Richard Steele, Jeff McKee, Andrew Muscroft-Taylor, Shanthi Ameratunga, Natalie Medlicott, Shyamal Das, William Rolleston, Miguel E Quiñones-Mateu, Helen Petousis-Harris, Anthony Jordan
100 YEARS AGO IN THE NZMJ
Organisation of National Health
ARTICLE
Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital
Michael Yoon Kang, Jessica Besley, Tina Sun, Sunita Paul
EDITORIAL
The Government’s proposal to legalise cannabis in New Zealand: 10 key questions
Chris Wilkins, Marta Rychert
ARTICLE
The New Zealand nuclear veteran and families study, exploring the options to assess heritable health outcomes
John Dockerty, James Jolly, Asutosh Kumar, Trent Larsen, Bill Lu, David Iain McBride, Sam McGill, Robin Turner, Sonia Wall, Stephanie Williams, Alan Yi, Anastasia Gough-Young
VIEWPOINT
The practice of the alcohol industry as health educator: a critique
Nicki Jackson, Rachael Dixon
VIEWPOINT
A balanced opinion? Considering the role of the external clinical advisor in ACC processes
Andrew Dickson, Joanna Manning
CLINICAL CORRESPONDENCE
Acute onset internuclear ophthalmoplegia responsive to treatment with intravenous alteplase
Karim M Mahawish, Adarsh Aravind
ARTICLE
Attitudes towards cannabis and cannabis law change in a New Zealand birth cohort
Joseph M Boden, Lana Cleland, Bhubaneswor Dhakal, L John Horwood
LETTER
Beyond COVID-19: five actions which would improve the health of all New Zealanders
Emma Espiner, Selah Hart, Garth Poole, Tamara Glyn Mullaney, Su Mei Hoh
ARTICLE
Cannabis-based medicinal products in arthritis, a painful conundrum
Marthe Van den Berg, Mary John, Melissa Black, Alex Semprini, Karen Oldfield, Michelle Glass, Irene Braithwaite
VIEWPOINT
Challenges of virtual talking therapies for substance misuse in New Zealand during the COVID-19 pandemic: an opinion piece
Susanna Galea-Singer, David Newcombe, Virginia Farnsworth-Grodd, Janie Sheridan, Peter Adams, Natalie Walker
ARTICLE
Exploring medicinal use of cannabis in a time of policy change in New Zealand
Marta Rychert, Chris Wilkins, Karl Parker, Thomas Graydon-Guy
ARTICLE
Increasing burden of advanced hepatocellular carcinoma in New Zealand—the need for better surveillance
Cameron Schauer, Thomas Mules, Marius van Rijnsoever, Ed Gane
VIEWPOINT
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection
Rohan Ameratunga, Klaus Lehnert, Euphemia Leung, Davide Comoletti, Russell Snell, See-Tarn Woon, William Abbott, Emily Mears, Richard Steele, Jeff McKee, Andrew Muscroft-Taylor, Shanthi Ameratunga, Natalie Medlicott, Shyamal Das, William Rolleston, Miguel E Quiñones-Mateu, Helen Petousis-Harris, Anthony Jordan
100 YEARS AGO IN THE NZMJ
Organisation of National Health
ARTICLE
Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital
Michael Yoon Kang, Jessica Besley, Tina Sun, Sunita Paul
EDITORIAL
The Government’s proposal to legalise cannabis in New Zealand: 10 key questions
Chris Wilkins, Marta Rychert
ARTICLE
The New Zealand nuclear veteran and families study, exploring the options to assess heritable health outcomes
John Dockerty, James Jolly, Asutosh Kumar, Trent Larsen, Bill Lu, David Iain McBride, Sam McGill, Robin Turner, Sonia Wall, Stephanie Williams, Alan Yi, Anastasia Gough-Young
VIEWPOINT
The practice of the alcohol industry as health educator: a critique
Nicki Jackson, Rachael Dixon
